Abstract:Background The global coronavirus disease 2019 (COVID-19) pandemic seriously affected people's lives. We evaluated anxiety and depression among patients with insomnia in northeast China during the first wave and release of COVID-19, providing a basis for the clinical diagnosis and treatment of insomnia. Methods We enrolled 4211 patients with insomnia from January 2016 to February 2020, August 2020 to February 2022, August 2022 to December 2022, and January 2023 to February 2023, from our institution. Sleep quality was evaluated using the Athens Insomnia Scale, Insomnia Severity Index (ISI), and Pittsburgh sleep quality index (PSQI), while mood disorder and fatigue were evaluated using the Hhospital anxiety and depression scale (HAD), Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder (GAD-7), and Fatigue Scale-14 (FS-14). Results Insomnia with depression increased in prevalence after COVID-19 compared with before (12.8¬†% vs. 15.3¬†%, P ¬†<¬†0.05), while the age of patients decreased [(50.2¬†¬Ī¬†15.2) vs. (47.5¬†¬Ī¬†16.8), P ¬†<¬†0.05]. The number of patients with insomnia and severe depression increased compared with before COVID-19 (20.3¬†% vs. 25.3¬†%, P ¬† 2¬†years had depression ( P ¬†<¬†0.05). As the epidemic subsided, insomnia increased among young and male patients (young patients: 55.2¬†% vs. 37.0¬†%; male patients: 41¬†% vs. 27.4¬†%, respectively; P ¬†<¬†0.05). The proportion of patients with insomnia with anxiety and depression increased (53.8¬†% vs. 51.8¬†%, P ¬†<¬†0.05), the proportion with moderate to severe anxiety increased (7.6¬†% vs. 13.5¬†%, P ¬†<¬†0.05), and moderate and severe depression decreased (moderate: 25.6¬†% vs. 19.1¬†%, severe: 25.8¬†% vs. 20.3¬†%, P ¬†<¬†0.05, respectively). Middle-aged and elderly patients had higher PQSI scores in sleep latency, habitual sleep efficiency, subjective sleep quality, and use of sleep medications than young patients ( P ¬†<¬†0.05). The PSQI score was positively correlated with the PHQ-9 score ( r ¬†=¬†0.526), GAD-7 score ( r ¬†=¬†0.563), and FS-14 score ( r ¬†=¬†0.316) ( P ¬†<¬†0.05). Limitations The study was single-center, the sample size was small, and assessment data were lacking from early in the epidemic. The scale is subjective, which may affect the accuracy. Conclusion Insomnia with depression increased during COVID-19. The patients were younger than before the epidemic, and a higher proportion with insomnia for >2¬†years had depression. The proportion of patients with insomnia with anxiety and depression was higher after the epidemic period, and the degree worsened. The proportion of insomnia with depression decreased after the epidemic period, and the degree alleviated. The proportion of young male patients with insomnia increased. Middle aged and elderly patients with insomnia had poor sleep quality, which was positively correlated with anxiety, depression, and fatigue.

Anxiety, depression, insomnia symptoms & associated factors among young to middle-aged adults during the resurgent epidemic of COVID-19: a cross-sectional study

Anxiety and depression levels and their influencing factors in community-dwelling patients with schizophrenia in China during the COVID-19 pandemic

Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 epidemic in China: a web-based cross-sectional survey

Mental Health Status of Late-Middle-Aged Adults in China During the Coronavirus Disease 2019 Pandemic

Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based cross-sectional survey

Status and influential factors of anxiety depression and insomnia symptoms in the work resumption period of COVID-19 epidemic: A multicenter cross-sectional study

Prevalence and Associated Factors for Depressive Symptomatology in Chinese Adults During COVID-19 Epidemic

Sleep problems among Chinese adolescents and young adults during the coronavirus-2019 pandemic

Epidemiology of Sleep Disturbances and Their Effect on Psychological Distress During the COVID-19 Outbreak: A Large National Study in China

The Prevalence of and Factors Associated with Anxiety and Depression among Working-Age Adults in Mainland China at the Early Remission Stage of the Coronavirus 2019 Pandemic

Depressive, anxiety, and insomnia symptoms between population in quarantine and general population during the COVID-19 pandemic: a case-controlled study

The Combined Impact of Gender and Age on Post-traumatic Stress Symptoms, Depression, and Insomnia During COVID-19 Outbreak in China

Mental Health Disorders and Associated Risk Factors in Quarantined Adults During the COVID-19 Outbreak in China: Cross-Sectional Study

Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China

A nationwide evaluation of the prevalence of and risk factors associated with anxiety, depression and insomnia symptoms during the return-to-work period of coronavirus disease 2019 in China

Anxiety and depression levels of the general population during the rapid progressing stage in the coronavirus disease 2019 outbreak: a cross-sectional online investigation in China

Anxiety and depression among patients with insomnia during the first wave and the release of the COVID-19 in Northeast China: A cross-sectional survey

COVID-19 pandemic related long-term chronic stress on the prevalence of depression and anxiety in the general population

Sleep Disturbance and Anxiety Symptom among Public During the Second Wave of COVID-19 in Beijing: A Web-Based Cross-Sectional Survey

Prevalence of psychological disorders in the COVID-19 epidemic in China: A real world cross-sectional study

Mental health problems and correlates among 746 217 college students during the coronavirus disease 2019 outbreak in China